IndiaOne Finance - Company Dashboard

Governance Classic Home

Morepen Laboratories LtdPharmaceuticalsINE083A01026Consolidated₹120.90+0.34 (+0.28%)Jun-26

Valuation

Market Cap₹6.62K Cr

TTM PE47.23x

Forward PE50.10x

PEG0.98

Book Value₹22.75

P/B5.31x

TTM EPS₹2.56

Fwd EPS₹2.41

TTM Revenue₹1.95K Cr

TTM PAT₹140.53 Cr

TTM EBITDA₹184.01 Cr

TTM EBIT₹148.25 Cr

Last Qtr PAT₹56.40 Cr

Last Qtr EBITDA₹82.54 Cr

Last Qtr EBIT₹74.19 Cr

Profitability

ROE11.27%

ROCE13.49%

TTM NPM7.20%

TTM EBITDA %9.43%

Curr OPM9.80%

Last OPM3.19%

Curr NPM—

Last NPM—

Curr EPS₹1.03

Last EPS₹0.28

Balance sheet

Equity₹109.58 Cr

Reserve₹1.14K Cr

Total Debt₹207.85 Cr

D/E0.17x

Interest %8.58%

Curr Interest₹4.84 Cr

Price / range

Close₹120.90

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+0.28%

1W+4.42%

1M+36.70%

3M+136.92%

6M+212.81%

1Y+124.05%

2Y+39.40%

3Y+224.22%

5Y+100.83%

Diwali+194.30%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	541.04+38.3%	462.81	457.57	369.53	391.28	1,681.20
Other Income	5.31	8.82	3.93	4.65	4.09	21.50
Total Income	546.35+38.2%	471.63	461.50	374.18	395.38	1,702.69
Interest	4.78	3.87	4.31	4.11	3.81	16.10
Expenditure	-474.20-23.5%	-444	-430.08	-356.41	-384.02	-1,614.52
PBDT	0	0	0	0	0	0
EBITDA	79.60+320.1%	23.31	41.89	27.93	18.95	112.09
Depreciation	-7.98	-0.63	-10.09	-10.70	-7.88	-29.31
EBIT	71.62+547.0%	22.68	31.80	17.23	11.07	82.78
PBT	72.15+535.7%	27.63	31.42	18.86	11.35	89.26
Tax	-18.15	-7.50	-7.93	-4.49	-3.29	-23.21
Equity	109.58	109.58	0	0	109.58	109.58
OPM	13.21	5.86	6.87	5.10	2.87	5.24
Net Profit	54+570.0%	20.12	23.50	14.38	8.06	66.06
NPM	9.88	4.27	5.13	3.89	2.04	3.88
EPS	0.99+560.0%	0.37	0.43	0.26	0.15	1.21

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,681.20+8.1%	1,554.54+1.1%	1,537.59+14.8%	1,338.88-7.6%	1,449.27+30.3%	1,112.42
Other Income	21.50	15.72	12.57	5.76	10.24	11.77
Total Income	1,702.69+8.4%	1,570.25+1.3%	1,550.16+15.3%	1,344.64-7.9%	1,459.50+29.8%	1,124.20
Expenditure	-1,614.52-12.7%	-1,432.67-2.2%	-1,401.18-9.3%	-1,281.60+3.9%	-1,333.96-29.5%	-1,029.95
Interest	-16.10	-7.10	-3.51	-1.98	7.37	-1.79
PBDT	0	0	0	0	0	0
EBITDA	112.09-26.9%	153.41-5.2%	161.82+109.4%	77.27-46.3%	143.88+28.0%	112.37
Depreciation	-29.31	-24.44	-21.90	-18.01	-21.20	-28.11
EBIT	82.78-35.8%	128.97-7.8%	139.92+136.1%	59.26-51.7%	122.68+45.6%	84.26
PBT	89.26-35.1%	137.59-7.6%	148.98+136.3%	63.04-49.8%	125.54+33.2%	94.25
Tax	-23.21	-36.01	-38.04	-16.80	-24.48	0
Equity	109.58	109.58	0	0	0	0
OPM (%)	5.24	8.76	10.00	5.00	9.00	8.00
Net Profit	66.06-35.0%	101.58-8.4%	110.94+139.9%	46.24-54.2%	101.06+7.2%	94.25
NPM (%)	3.88	6.47	7.00	3.00	7.00	8.00
EPS (Rs)	1.21-36.3%	1.90-12.4%	2.17+135.9%	0.92-59.1%	2.25+7.1%	2.10
CEPS	1.21	1.90	2.17	0.92	1.94	2.09

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	570.13+34.1%	484.72	484.16	411.58	425.24	1,805.69
Other Income	5.18	8.46	3.81	4.64	4.41	21.31
Total Income	575.31+33.9%	493.18	487.97	416.21	429.65	1,827.01
Interest	4.84	3.88	4.32	4.18	4.04	16.41
Expenditure	-500.78-20.9%	-469.89	-452.55	-396.34	-414.13	-1,732.91
PBDT	0	0	0	0	0	0
EBITDA	82.54+241.4%	24.46	46.31	30.70	24.18	125.62
Depreciation	-8.35	-5.75	-10.38	-11.28	-9.03	-36.43
EBIT	74.19+389.7%	18.71	35.93	19.42	15.15	89.19
PBT	74.53+380.2%	23.29	35.42	45.70	15.52	119.92
Tax	-18.18	-7.59	-7.93	-4.65	-4.11	-24.27
Equity	109.58	109.58	0	0	109.58	109.58
OPM	12.95	4.72	7.26	10.98	3.61	6.56
Net Profit	56.40+424.7%	15.74	27.51	40.88	10.75	94.88
NPM	9.80	3.19	5.64	9.82	2.50	5.19
EPS	1.03+415.0%	0.28	0.50	0.75	0.20	1.73

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,805.69-0.3%	1,811.58+7.2%	1,690.43+19.3%	1,417.53-8.4%	1,546.83+30.2%	1,188.06
Other Income	21.31	18.36	13.97	6.13	10.31	12.07
Total Income	1,827.01-0.2%	1,829.94+7.4%	1,704.40+19.7%	1,423.66-8.6%	1,557.13+29.7%	1,200.13
Expenditure	-1,732.91-3.5%	-1,674.83-6.7%	-1,568.99-14.7%	-1,367.91+4.4%	-1,430.43-29.8%	-1,101.61
Interest	-16.41	-8.34	-3.71	-1.98	7.37	-1.79
PBDT	0	0	0	0	0	0
EBITDA	125.62-27.8%	174.07+9.7%	158.62+99.4%	79.53-47.5%	151.41+27.8%	118.52
Depreciation	-36.43	-28.98	-33.47	-27.93	-27.64	-30.28
EBIT	89.19-38.5%	145.09+15.9%	125.15+142.5%	51.60-58.3%	123.77+40.3%	88.24
PBT	119.92-22.7%	155.11+14.5%	135.42+142.9%	55.76-56.0%	126.70+28.6%	98.51
Tax	-24.27	-37.09	-38.80	-17.08	-25.02	-1.42
Equity	109.58	109.58	0	0	0	0
OPM (%)	6.56	8.48	7.95	3.92	8.14	8.21
Net Profit	94.88-19.6%	118.02+22.7%	96.16+148.6%	38.68-62.0%	101.68+4.7%	97.09
NPM (%)	5.19	6.45	5.64	2.72	6.53	8.09
EPS (Rs)	1.73-21.4%	2.20+17.0%	1.88+144.2%	0.77-65.9%	2.26+4.6%	2.16
CEPS	1.73	2.20	1.88	0.77	1.96	2.15

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	0.2	18 Sep 2026
2025	Final Dividend	0.2	29 Aug 2025

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split